ArticleBritish journal of cancer2017

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.

Muhammad A Alvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.